Pressmeddelande -
RayPilot® publication wins award for best poster at ESTRO in Barcelona.
During Europe's largest convention in radiotherapy ESTRO, a scientific publication containing the RayPilot® system for increased precision in radiotherapy, was awarded as the winner under the category Best Young Physics Poster Award.
The award winning poster entitled "Time-resolved evolvement of target dose distribution during IMAT with and without dynamic MLC tracking" comes from the research that began in 2010 with the RayPilot® system in a collaboration between the Aarhus University Hospital in Denmark and Sydney Medical School in Australia.
This work demonstrates future application areas and possibilities of the RayPilot® system which in this case studied what happens to the radiation dose when RayPilot® is used to obtain real-time MLC tracking of the target volume. The conclusion is that by following the target continuously the risk of deliver the wrong dose to the target significantly is reduced.
This publication is one of five scientific publications related to the RayPilot® system that was presented at the ESTRO convention in Barcelona.
- It feels great that we now after several years of just talking about the RayPilot® system's potential, actually starting to get more and more independent publications that support both the current functionality for real time tracking of the prostate and also on future applications under development says Tomas Gustafsson, CEO of Micropos Medical.
The following scientific papers were presented at the congress:
Sahlgrenska University Hospital, Sahlgrenska Academy at Göteborg University
Clinical experience of real-time tracking with the raypilot system in patients with prostate cancer
Aarhus University Hospital (Danmark)
Three dimensional optical gel dosimetry of target tracking in radiotherapy
Aarhus University Hospital (Danmark), Sydney Medical School (Australia) - Best Young Physics Poster Award
Karolinska University Hospital
Patient evaluation of the raypilot system during radiation therapy of prostate cancer
Karolinska University Hospital, Sahlgrenska University Hospital, Uddevalla Hospital
For further information contact:
Tomas Gustafsson, CEO, Micropos Medical AB (publ), +46-31-772 80 99
Ämnen
- Hälsa, sjukvård, läkemedel
Kategorier
- aktietorget
- cancer
- micropos medical
- radiotherapy
- tomas gustafsson
- raypilot
- prostate cancer
- electromagnetic positioning
- dosimetry
- sahlgrenska university hospital
- karolinska university hospital
- aarhus university hospital
- sydney medical school
- uddevalla hospital
Regioner
- Göteborg
About Micropos Medical AB (publ):
Micropos Medical AB (publ) (www.micropos.se) is a Swedish medical device start-up that was founded in 2003 as a result of four physicians’ long clinical experience in the therapeutic radiation oncology field (cancer treatment). The company has developed the RayPilot® system for increased precision in radiotherapy of prostate cancer. The RayPilot® system is an electromagnetic positioning system that initially enables real time position of the prostate for a fast and objective set-up and for continuous positioning during the treatment. A precise and safe localization of the tumor can dramatically improve the outcome of the treatment, particularly for hypofractionated protocols. The RayPilot® system consists mainly of three parts; a transmitter that is placed in the ROI, a receiving system that is placed directly on any existing treatment coach and software that continuously shows where the tumor is and where to beam. The transmitter is removed after the final treatment in order to enable MRI follow-up.
Now you can follow the company on Facebook, http://www.facebook.com/MicroposMedical or follow the press releases about the company on www.mynewsdesk.se search for Micropos and subscribe.
